AMRZ - Company ID 0002035989
The table below shows Amrize Ltd's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $2.18B | $3.67B | $3.22B | $2.08B | $3.45B | $3.24B |
| Cost of revenue | $1.97B | $2.59B | $2.25B | $1.86B | $2.40B | $2.26B |
| Gross profit | $211.00M | $1.09B | $966.00M | $222.00M | $1.04B | $979.00M |
| R&D | - | - | - | - | - | - |
Amrize Ltd reported annual revenue of $11.81B for fiscal year 2025. That is up 0.9% from $11.70B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $292.00M |
| $312.00M |
| $299.00M |
| $239.00M |
| $241.00M |
| $228.00M |
| Operating income | -$76.00M | $778.00M | $669.00M | -$16.00M | $844.00M | $754.00M |
| Income tax | -$27.00M | $150.00M | $122.00M | -$46.00M | $155.00M | $149.00M |
| Net income | -$116.00M | $545.00M | $429.00M | -$87.00M | $553.00M | $474.00M |
| EPS (diluted) | -$0.21 | $0.98 | $0.78 | -$0.16 | $1.00 | $0.86 |